Pereira Brian Jg sold 222,948 shares of PROKIDNEY CORP. at $1.42 for −$317k on Aug 20, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Aug 20, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$316,563.87Shares × reported price
Shares traded
222,948Class A Common Stock
Price per share
$1.42Reported price. Read footnotes for ranges.
% of reported position traded
100%This security and ownership context
Holdings after
0Indirect · By Brian J. G. Pereira 2012 Irrevocable Trust
Trade date
Aug 20, 2026Sell
Filed
Aug 20, 2026, 5:00 PM ET0-day reporting delay
Accession
0001193125-26-359349Code S · Transaction 13241
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 222,948 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 18, 2026Sell229,338$1.37−$314,468.27Trade 13237
Aug 18, 2026Sell27,826$1.37−$38,155.01Trade 13238
Aug 19, 2026Sell222,949$1.44−$321,202.62Trade 13239
Aug 19, 2026Sell27,051$1.44−$38,972.38Trade 13240
Aug 20, 2026Sell27,052$1.42−$38,411.13Trade 13242
6 transaction rows in this filing. Joint filers share the same rows.

PROK price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PROK · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +12%1w ago −1.4%1d ago +4.2%
Returns since7d +28%30d +35%90d180d1y

Footnotes in full

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.345 to $1.40, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.50, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.47, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.